Michael Hebeisen
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Phage display enables machine learning discovery of cancer antigen-specific TCRs.
Journal: Science advances
Published: June 11, 2025
Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.
Journal: Frontiers in immunology
Published: September 12, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
Journal: Nature communications
Published: June 21, 2022
CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
Journal: Frontiers in immunology
Published: June 20, 2022
Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.
Journal: European journal of immunology
Published: October 15, 2020
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells.
Journal: Science advances
Published: October 08, 2019
High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.
Journal: Frontiers in immunology
Published: September 29, 2019
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.
Journal: European journal of immunology
Published: August 15, 2019
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Journal: Journal for immunotherapy of cancer
Published: July 19, 2019
NK cells specifically TCR-dressed to kill cancer cells.
Journal: EBioMedicine
Published: November 08, 2018
TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.
Journal: JCI insight
Published: January 03, 2017
Last Updated: 09/26/2026